Clinical Profile and Treatment Patterns in Individuals with Type 2 Diabetes and Chronic Kidney Disease Who Initiate a GLP-1 Receptor Agonist: A Multinational Cohort Study

During 2012-2021, GLP-1 RA use steadily increased across multinational cohorts of patients with T2D and CKD, and persistence with treatment was high. GLP-1 use was independent of CKD severity.

Authors

Institutions

Publication Details

Journal
Diabetes Therapy
Published
2025-03-19
DOI
https://doi.org/10.1007/s13300-025-01717-8
Citations
4
Primary Topic
Diabetes Treatment and Management
Type
article
Field-Weighted Citation Impact
5.18

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Clinical Profile and Treatment Patterns in Individuals with Type 2 Diabetes and Chronic Kidney Disease Who Initiate a GLP-1 Receptor Agonist: A Multinational Cohort Study

Manel Pladevall, Aníbal García‐Sempere, Clara Rodríguez Bernal, Christian Fynbo Christiansen et al.
4 citations
Diabetes Therapy
Diabetes Treatment and Management
5.18
article

Clinical Profile and Treatment Patterns in Individuals with Type 2 Diabetes and Chronic Kidney Disease Who Initiate a GLP-1 Receptor Agonist: A Multinational Cohort Study

Manel Pladevall, Aníbal García‐Sempere, Clara Rodríguez Bernal, Christian Fynbo Christiansen, F. Kristensen, Alain Gay, Natalie Ebert, Alfredo E. Farjat, Michael Walsh, Naoki Kashihara, Patrick O. Gee, Catherine B. Johannes, Suguru Okami, Brenda N. Baak, Isabel Hurtado, David Vizcaya, Hiroshi Kanegae, Fernie J. A. Penning‐van Beest, Anam Khan, Ina Trolle Andersen, Yuichiro Yano, J. Bradley Layton, Daniel Mines, Reimar W. Thomsen, Nikolaus G. Oberprieler, Ryan Ziemiecki, Craig I Coleman, Ron M. C. Herings, Csaba Pal Kovesdy, Jetty A. Overbeek, Fangfang Liu, Satoshi Yamashita, Celia Robles Cabaniñas
article en
4 citations

Abstract

During 2012-2021, GLP-1 RA use steadily increased across multinational cohorts of patients with T2D and CKD, and persistence with treatment was high. GLP-1 use was independent of CKD severity.

Diabetes TherapyVol. 16(5)
Hartford Hospital (US), National Kidney Foundation (US), University of Connecticut (US), Henry Ford Health System (US), University of Tennessee Health Science Center (US), Kawasaki Medical School (JP), Aarhus University Hospital (DK), Juntendo University (JP), Genki Plaza Medical Center for Health Care (JP), Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (ES), RTI Health Solutions (US), Pharmo Institute (NL), Hartford Financial Services (United States), Bayer (Germany) (DE), Charité - Universitätsmedizin Berlin (DE), McMaster University (CA)
Bayer
Openalex Percentile: Top 5%
Diabetes Treatment and Management
5.18
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.